Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 82.3M
Gross Profit 53.7M 65.25%
Operating Income -7.1M -8.67%
Net Income -20.2M -24.54%
EPS (Diluted) -$0.44

Balance Sheet Metrics

Total Assets 399.5M
Total Liabilities 50.6M
Shareholders Equity 348.9M
Debt to Equity 0.14

Cash Flow Metrics

Operating Cash Flow 16.9M
Free Cash Flow 4.9M

Revenue & Profitability Trend

Biolife Solutions Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue82.3M143.3M161.8M119.2M48.1M
Cost of Goods Sold28.6M96.5M107.9M82.1M20.6M
Gross Profit53.7M46.8M53.8M37.0M27.4M
Operating Expenses58.1M99.1M84.0M59.5M28.4M
Operating Income-7.1M-57.5M-39.9M-30.6M-4.0M
Pre-tax Income-11.4M-66.3M-144.8M-29.0M-1.3M
Income Tax-38.0K169.0K-5.0M-20.1M-3.3M
Net Income-20.2M-66.4M-139.8M-8.9M2.0M
EPS (Diluted)-$0.44-$1.52-$3.29-$0.22$0.03

Income Statement Trend

Biolife Solutions Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets148.8M120.6M138.5M126.1M114.7M
Non-Current Assets250.7M292.1M311.8M428.2M120.1M
Total Assets399.5M412.7M450.2M554.3M234.8M
Liabilities
Current Liabilities32.7M42.2M44.6M42.7M15.6M
Non-Current Liabilities17.8M32.9M41.5M33.5M14.0M
Total Liabilities50.6M75.1M86.0M76.2M29.6M
Equity
Total Shareholders Equity348.9M337.7M364.2M478.0M205.2M

Balance Sheet Composition

Biolife Solutions Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-20.2M-66.4M-139.8M-8.9M2.0M
Operating Cash Flow16.9M-31.4M-122.6M-5.7M9.7M
Investing Activities
Capital Expenditures-3.2M-6.4M-10.4M-8.4M-4.6M
Investing Cash Flow58.6M17.8M-58.1M-13.2M-24.7M
Financing Activities
Dividends Paid-----
Financing Cash Flow-7.0M10.1M16.0M-35.7M100.6M
Free Cash Flow4.9M-18.9M-18.9M-13.0M2.0M

Cash Flow Trend

Biolife Solutions Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -50.75
Forward P/E -80.54
Price to Book 3.04
Price to Sales 12.22
PEG Ratio -80.54

Profitability Ratios

Profit Margin -11.86%
Operating Margin -5.09%
Return on Equity -2.52%
Return on Assets -0.79%

Financial Health

Current Ratio 4.73
Debt to Equity 7.64
Beta 1.82

Per Share Data

EPS (TTM) -$0.19
Book Value per Share $7.42
Revenue per Share $1.89

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
blfs1.1B-50.753.04-2.52%-11.86%7.64
Intuitive Surgical 189.7B77.3911.0915.96%28.41%0.00
Becton, Dickinson 50.0B33.871.985.89%7.18%76.34
Lemaitre Vascular 1.9B42.775.4813.77%19.96%53.33
AtriCure 1.6B-3.46-8.38%-7.95%17.03
Azenta 1.5B-10.800.90-8.58%-9.77%3.16

Financial data is updated regularly. All figures are in the company's reporting currency.